Lung Cancer

Published by: Elsevier Ireland Ltd.  

People

  1. Riely
    Riely
  2. Ginsberg
    Ginsberg
  3. Yu
    Yu
  4. Capanu
    Capanu
  5. Chaft
    Chaft
  6. Janjigian
    Janjigian
  7. Kris
    Kris
  8. Plodkowski
    Plodkowski
  9. Rekhtman
    Rekhtman
  10. Travis
    Travis

Groups

  1. Department of Medicine (7)
  2. Solid Tumor Oncology Division (6)
  3. Thoracic Oncology (5)
  4. Biostatistics Service (3)
  5. Epidemiology and Biostatistics (3)
  6. Body Imaging Service (2)
  7. Radiology, Department of (2)
  8. Center for Pancreatic Cancer Research (1)
  9. Dermatology Service (1)
  10. Dermatology (1)
Search Within
  1. "2017"
Formats
  1. Journal Article (7)
Groups
  1. Department of Medicine (7)
  2. Solid Tumor Oncology Division (6)
  3. Thoracic Oncology (5)
  4. Biostatistics Service (3)
  5. Epidemiology and Biostatistics (3)
  6. Body Imaging Service (2)

More Groups

People
  1. Gregory Riely (3)
  2. Darragh Halpenny (2)
  3. Helena Yu (2)
  4. Michelle Ginsberg (2)
  5. Sinead McEvoy (2)
  6. Abraham Wu (1)

More People

Years
  1. 2017 (7)
Publishers
  1. Elsevier Ireland Ltd. (7)

Results (7)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Continued use of afatinib with the addition of cetuximab after progression on afatinib in patients with EGFR mutation-positive non-small-cell lung cancer and acquired resistance to gefitinib or erlotinib
    Journal Article

    Horn, L.; Gettinger, S.; Camidge, D. R.; Smit, E. F.; Janjigian, Y. Y.; Miller, V. A.; Pao, W.; Freiwald, M.; Fan, J.; Wang, B.; more...
    Lung Cancer (2017)

    Fulltext@MSK | Save
  • Phase 2 study of intermittent pulse dacomitinib in patients with advanced non-small cell lung cancers
    Journal Article

    Yu, H. A.; Ahn, M. J.; Cho, B. C.; Gerber, D. E.; Natale, R. B.; Socinski, M. A.; Giri, N.; Quinn, S.; Sbar, E.; Zhang, H.; more...
    Lung Cancer (2017)

    Fulltext@MSK | Save
  • Prognostic impact of TTF-1 expression in patients with stage IV lung adenocarcinomas
    Journal Article

    Schilsky, J. B.; Ni, A.; Ahn, L.; Datta, S.; Travis, W. D.; Kris, M. G.; Chaft, J. E.; Rekhtman, N.; Hellmann, M. D.
    Lung Cancer (2017)

    Fulltext@MSK | Save
  • Patterns of initial and intracranial failure in metastatic EGFR-mutant non-small cell lung cancer treated with erlotinib
    Journal Article

    Patel, S. H.; Rimner, A.; Foster, A.; Zhang, Z.; Woo, K. M.; Yu, H. A.; Riely, G. J.; Wu, A. J.
    Lung Cancer (2017)

    Fulltext@MSK | Save
  • Investigation of patterns of nodal metastases in BRAF mutant lung cancer
    Journal Article

    McEvoy, S. H.; Halpenny, D. F.; Viteri-Jusué, A.; Hayes, S. A.; Plodkowski, A. J.; Riely, G. J.; Ginsberg, M. S.
    Lung Cancer (2017)

    Fulltext@MSK | Save
  • Impact of a planned dose interruption of dacomitinib in the treatment of advanced non-small-cell lung cancer (ARCHER 1042)
    Journal Article

    Kim, D. W.; Garon, E. B.; Jatoi, A.; Keefe, D. M.; Lacouture, M. E.; Sonis, S.; Gernhardt, D.; Wang, T.; Giri, N.; Doherty, J. P.; more...
    Lung Cancer (2017)

    Fulltext@MSK | Save
  • Renal cyst formation in patients treated with crizotinib for non-small cell lung cancer—Incidence, radiological features and clinical characteristics
    Journal Article

    Halpenny, D. F.; McEvoy, S.; Li, A.; Hayan, S.; Capanu, M.; Zheng, J.; Riely, G.; Ginsberg, M. S.
    Lung Cancer (2017)

    Fulltext@MSK | Save

    • Lung Cancer – authorized name for:

    Name ISSN / ISBN Publisher
    Lung Cancer 0169-5002 Elsevier Ireland Ltd.
    Lung Cancer 0169-5002 Elsevier Inc.
    Lung Cancer 0169-5002 Elsevier Inc.
    Lung Cancer 01695002 Elsevier Science Ireland Ltd
    Lung Cancer 0169-5002 Elsevier Ireland Ltd.
    Lung Cancer 0169-5002 Elsevier Ireland Ltd.
    Lung Cancer 01695002 2019
    Lung Cancer 01695002 1995
    Lung Cancer 0169-5002 Elsevier Sci Publ Ireland Ltd
    Lung Cancer 0169-5002 Elsevier Ireland Ltd.
    Lung Cancer 01695002 1993
    Lung Cancer 0169-5002 Elsevier Science, Inc.
    Lung Cancer 18728332 Elsevier Ireland Ltd.
    Lung Cancer 0169-5002 Elsevier B.V.
    Lung Cancer 1872-8332 Elsevier Ireland Ltd.
    Lung Cancer 0169-5002 Elsevier Ireland Ltd.
    Lung Cancer 1695002 Elsevier Ireland Ltd.
    Lung Cancer 0169-5002 Elsevier Ireland Ltd.
    Lung Cancer 0169-5002 Unknown
    Lung Cancer 01695002 The Author(s)
    Lung Cancer 0169-5002 Elsevier Ireland Ltd.
    Lung Cancer 0169-5002 Elsevier Ireland Ltd.
    Lung Cancer 01695002 Elsevier Ireland Ltd.
    Lung Cancer 0169-5002 Elsevier Ireland Ltd.
    Lung Cancer 01695002 Unknown
    Lung Cancer 0169-5002 Elsevier Ireland Ltd.
    Lung Cancer 01695002 2017
    Lung Cancer 01695002 Elsevier B.V.
    Lung Cancer 01695002 2018
    Lung Cancer 0169-5002 Elsevier Ireland Ltd.
    Lung cancer (Amsterdam, Netherlands) 01695002 Unknown